Chemistry: molecular biology and microbiology – Spore forming or isolating process
Patent
1982-05-26
1985-04-30
Hazel, Blondel
Chemistry: molecular biology and microbiology
Spore forming or isolating process
260112R, 424 85, 424 87, 4351722, 935103, 935104, 935105, C12N 500, C12N 1500, C07G 700
Patent
active
045144982
ABSTRACT:
Continuous hybrid cell lines for producing monoclonal antibodies directed against antigens of Treponema pallidum have been developed. The hybrid cell lines were established by fusing differentiated lymphoid cells primed with antigens of Treponema pallidum with hybridoma cells. The resulting fused cells were cloned, isolated, cultured and characterized as to antibody specificity against antigenic determinants of Treponema pallidum.
REFERENCES:
patent: 4172124 (1979-10-01), Koprowski et al.
patent: 4196265 (1980-04-01), Koprowski et al.
patent: 4271145 (1981-06-01), Wands et al.
Kennett et al., "Hybrid Plasmacytoma Production: Fusions with Adult Spleen Cells, Monoclonal Spleen Fragments, Neonatal Spleen Cells and Human Spleen Cells", Lymphocyte Hybridomas, ed. by Melchers et al., Current Topics in Microbiology and Immunology, Springer-Verlag, Berlin, 1978, pp. 77-91.
Microbiology, Pelczar, Jr. et al., McGraw-Hill, New York, 1972, pp. 624-625.
Glass, David, "Medicine's Micro Missiles", Science Digest, 30-31:114, (Jan. 1982).
Miller, J. N., "Value and Limitations of Nontreponemal and Treponemal Tests in the Laboratory Diagnosis of Syphilis", Clinical Obstetrics and Gynecology, 18:191-203 (1975).
Kettman John R.
Norgard Michael V.
Hazel Blondel
The Board of Regents The University of Texas System
LandOfFree
Hybrid cell lines producing monoclonal antibodies directed again does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hybrid cell lines producing monoclonal antibodies directed again, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hybrid cell lines producing monoclonal antibodies directed again will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1968834